Elucidating the exact pharmacological mechanism of action (MOA) of naturally occurring compounds is often challenging. Although Tarselli et al. (60) formulated the main de novo artificial pathway to conolidine and showcased this naturally occurring compound successfully suppresses responses to each chemically induced and inflammation-derived pain, the pharmacologic target liable https://edmundj542egh2.bcbloggers.com/profile